pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Monoclonal Antibody · news · pharmadog
← back to Monoclonal Antibody
News · Monoclonal Antibody
553
stories
Aug 20, 26
Merck’s Moderna-partnered vaccine success clears view of post-Keytruda future
biospace
Aug 20, 26
Chai tees up Bristol Myers Squibb AI antibody discovery collab
fiercebiotech
Aug 20, 26
Why Pheast’s CEO has no regrets about transparent approach to R&D despite competitors circling
fiercebiotech
Aug 19, 26
FDA approves Regeneron’s garetosmab for disease that turns tissue to bone
endpoints
Aug 19, 26
Bristol Myers' partner Biokin says bispecific ADC clears fourth cancer trial in China
endpoints
Aug 19, 26
Amylyx’s redemption story, Summit’s survival woes, Definium’s anxiety win, more
biospace
Aug 18, 26
Sandoz inks $322M Henlius deal for rights to as many as 10 biosimilars
biospace
Aug 18, 26
Rebounding biotech funds expected to spur CDMO growth within year
biospace
Aug 18, 26
Regeneron ends eye disease study due to antibody's safety profile
biospace
Aug 18, 26
Regeneron ends eye disease study due to antibody's safety profile
biospace
Aug 17, 26
Argenx jumps on Phase 3 data for blockbuster Vyvgart
biopharma dive
Aug 17, 26
AstraZeneca scraps Phase 3 trial of new bispecific in lung cancer
biopharma dive
Aug 17, 26
AstraZeneca touts separate late-stage lung cancer wins with Tagrisso, Enhertu
endpoints
Aug 17, 26
Summit, Akeso's ivonescimab shows smaller benefit with longer follow-up in China
endpoints
Aug 17, 26
Slate, Fulcrum to combine in reverse merger
biopharma dive
Aug 17, 26
Summit, Akeso’s China approval celebration cut short as survival benefit degrades
biospace
Aug 17, 26
Regeneron ends eye disease trial for anti-CD3 antibody following safety review
fiercebiotech
Aug 17, 26
AstraZeneca pulls plug on late-stage lung cancer trial, taking another clinical blow
biospace
Aug 17, 26
AstraZeneca pulls plug on late-stage lung cancer trial, taking another clinical blow
biospace
Aug 17, 26
Argenx declares Phase 3 win for Vyvgart Hytrulo in autoimmune myositis
endpoints
Aug 17, 26
Slate uses Fulcrum to vault onto Nasdaq with $245M financing for migraine trials
fiercebiotech
Aug 17, 26
Lilly pens $370M deal with OmniAb for ion channel collab, but details remain vague
fiercebiotech
Aug 17, 26
AstraZeneca ends phase 3 lung cancer trial after bispecific falls short versus Keytruda
fiercebiotech
Aug 14, 26
Biogen's monoclonal antibody felzartamab wins first global approval in China
endpoints
Aug 14, 26
STAT+: PBMs agree to display TrumpRx drug prices
stat
Aug 14, 26
MapLight presses the pause button; ADC Therapeutics considers what to do with Zynlonta
endpoints
Aug 14, 26
Capricor shares spike on CEO comments; Cytokinetics sues Bristol Myers
biopharma dive
Aug 14, 26
STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class
stat
Aug 14, 26
Biotech initiatives pick up as more regions race to become hubs
biopharma dive
Aug 13, 26
STAT+: Eli Lilly targets booming black market for retatrutide
stat
← prev
page 8 of 19
next →
